Edesa Biotech (EDSA) Tops Q1 EPS by 67c

Edesa Biotech (NASDAQ: EDSA) reported Q1 EPS of ($0.54), $0.67 better than the analyst estimate of ($1.21).

For earnings history and earnings-related data on Edesa Biotech (EDSA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Medtronic completes $550 million Scientia Vascular acquisition
• Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors